In the STROBE Statement we use the acronym HTI (hospital-treated incidents) meaning "acute/subacute hospital-treated somatic disease incidents". In the paper we do not use HTI, but the terms "hospital treatment episodes", "treatment episodes" or "episodes", dependent on the context, meaning "acute/subacute hospital-treated somatic disease incidents".
Introduction
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported:
The impact of OMT status (before, during, after OMT) on somatic co-morbidity among dependent opioid users is yet poorly studied. The present study investigates how somatic co-morbidity varies according to OMT status (before, during and after OMT) in a group of 200 patients.
Objectives 3 State specific objectives, including any prespecified hypotheses:
The research questions were: Is somatic morbidity reduced during OMT compared to before and after treatment? If so, what kinds of disease incidents are reduced? How is the effect of OMT-status on somatic morbidity influenced by various patient characteristics?
Methods

Study design 4
Present key elements of study design early in the paper: Cohort design. Retrospective registration of acute/subacute somatic disease incidents treated in hospitals, 200 participants. "Historic" prospective registration of drug-use during OMT (annual individual reports form the national OMT programme from 2001 on), 183 participants. Information on patient characteristics from the annual reports (183 participants) and a structured interview (136 participants). 2) Patients should have contact with or be known by local heath or social services in the two actual counties at the time of invitation. Identity of patients was unknown to the research group until consent was obtained, participants were recruited by treatment personnel in local health and social treatment services including pharmacies. Selection of patients: 38 patients who met eligibility criteria 1) did not meat criteria 2) and were impossible to reach and considered as ineligible. All eligible patients (281) were invited to participate. 13 were dead after start of first OMT period and included, 187 consented. Altogether 200 were included and comprised the cohort.
Participants 6 (b) For matched studies, give matching criteria and number of exposed and unexposed: Not a matched study. Interrater reliability was tested in a pilot study 1 and was found to be good. In this study the fist author scrutinized all full-text hospital records. HTIs assessed difficult to categorize, was discussed with one of the co-authors (specialist of internal medicine and infectious diseases) until consensus was reached.
Data sources/ measurement 8* For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group:
HTIs: Records from somatic departments in local hospitals (Innlandet Hospital) was examined for all patients. Based on interview information, records from somatic departments in hospitals were patients reported to have received treatment, were requested. HTIs were categorized according the criteria in section 7. Number of incidents and inpatient days and outpatient contacts were counted. Only somatic incidents were included. One incident causing several treatment contacts were assessed as one incident. (n=200) Gender: The consent statement (n=187 + the dead, n=200). Age at OMT start: Annual reports from the OMT programme (n=197). Information from other sources (social service personnel) than interview available for a few.
Age at heroin debut: Interview (n=131). Years of opioid addiction before OMT start: Interview (n=130). Years of schooling: Interview (n=138). Information from other sources than interview available for a few.
Years of employment: Interview (n=135).
Lifetime number of overdoses: Interview (n=134)
Having experienced OMT cessation: Annual reports from the OMT programme, hospital records, interview, information from social service personnel, (n=200).
Ongoing use of illicit drugs during OMT (opioids, benzodiazepines, cannabis, central stimulants):
Annual reports from the OMT programme (n=183). Assessment of use of illegal opioids, benzodiazepines, cannabis and central stimulants based on urine tests, patient information and clinical assessment the last four weeks before date of report for every year during OMT. A combined score for drug use between zero (no reported drug use during treatment) and one (reported use of all drug types every year during treatment) was calculated. Assessment of drug use at the time of OMT cessation: Data on this available from annual reports for 41out of 51 with interrupted OMT.
Bias 9
Describe any efforts to address potential sources of bias: Recall bias: Information on hospital treatment outside the local area was based on patient recall and some disease incidents prior to treatment may have been overlooked. Altered help-seeking behaviour: Closer contact with health services during OMT probably increases patients' help-seeking resulting in hospital treatment for health problems that would not have been treated before OMT. Age: The patients were five years older during OMT than in the pre-OMT period, causing an age-dependent increase in morbidity. Selection bias: 38 out of 319 OMT-patients were excluded as they were regarded not eligible. Some of these had moved abroad or to other parts of the country, and probably do not differ much from the rest. Others could not be reached as they had terminated
OMT and had no current contact with social services. There might be an accumulation of "problem patients" among these, as among those who did not consent to participate.
However, the participation rate among those not in OMT when invited was about the same as among the ones in treatment, making it unlikely that this factor should cause considerable bias. Finally, more than 99 % of requested hospital records were obtained.
Hence, selection bias was probably of limited importance in the study.
Study size 10
Explain how the study size was arrived at:
Pilot study: disease incidents were registered. There was a reduction in all incidents by 35% (p = 0.004), in substance-related incidents by 62% (p < 0.001) and in injection-related incidents by 70% (p < 0.001). There was an insignificant reduction in non-fatal overdose incidents by 44% (p = 0.127) and an insignificant increase in non-substancerelated incidents by 13% (p = 0.741). Inpatient and outpatient days were reduced by 76% (p = 0.003) and 46% (p = 0.060), respectively. The disease incidents were less often drug-related during OMT (p < 0.001). Patients experienced a reduction in substance-related disease incidents regardless of ongoing substance use; however there was a trend towards greater reductions in those without ongoing abuse.
In the light of these results a sample/cohort size of about 200 was estimated as sufficient to evaluate whether non-significant tendencies in the pilot study would prove to be significant in a greater sample. Further, a cohort from a greater geographical area consisting av municipalities of different size and character would balance possible distinctive qualities concerning the municipality in the pilot study (municipality Gjoevik).
Quantitative variables 11
Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why:
HTIs: Numbers of HTIs and numbers of inpatient days and outpatient hospital contacts split in diagnostic categories according to OMT status (before, during, after OMT) were registered. Incidence rates (IR) and rates of inpatient days and outpatient contacts per 100 patient years for different types of HTIs before, during and after OMT were calculated.
Grouping is logical as changes in IR for various types of HTIs (as a proxy indicator of changes in acute/sub-acute morbidity) according to OMT status is the principal aim of the study.
Age at OMT start: Age intervals of five years were examined in the regression analyses. Age at heroin debut: Age intervals of five years were examined in the regression analyses.
Years of opioid addiction before OMT start: Age intervals of five years were examined in the regression analyses.
Years of schooling:
Put into four categories: 1) Not completed 9 years compulsory schooling, 2) Completed 9 years, 3) Completed 12 years (high-school), 4) More than 12 years (college, university) Years of employment: Put into three categories: 1) Less than one year ordinary employment, 2) 1-5 years, 3) More than 5 years.
Lifetime number of overdoses:
Put into four categories: 1) Zero, 2) 1-2, 3) 3-10, 4) More than 10.
Ongoing use of illicit drugs during OMT (opioids, benzodiazepines, cannabis, central stimulants): See point 8. Scores between 0 and 1 was split in 0.2 units by estimation of crude incidence rate ratio (IRR) and in quartiles in interaction analyses vs OMT status. Groupings of the variables were assessed appropriate to evaluate the patient characteristics in the analyses. (c) Explain how missing data were addressed: Data on patient characteristics from the interview was available for about 70 % of the cohort; this is a limitation in the study although 70 % is a fairly satisfactory interview rate among this group of patients. Outcome data 15* Report numbers of outcome events or summary measures over time
Acute/subacute hospital-treated disease incidents (HTI): Incidence rates and rates of inpatient days and outpatient treatment contacts per 100 patient years O M T s t a t u s
Before During After Using this design with repeated measures (incidence rates) of the same participants (before, during and after OMT) with Poisson regression (GEE), the estimates are incidence rate ratioes and not relative risk.
Other analyses 17 Report other analyses done-eg analyses of subgroups and interactions, and sensitivity analyses:
In the Poisson regression model used in this study, incidence rate is the dependent variable. The effect of several exposure/independent variables on the incidence rate of drug related HTIs were examined (this analysis is not in the paper): Heroin debut p = 0.28 per 5 years 0.9 (0.7 -1.1)
Interaction analysis:
Drug-related hospital-treated somatic disease incidents: interaction effect between OMT status (before versus during OMT) and patient characteristics. 
Patient characteristics P-value for
Discussion
Key results 18
Summarise key results with reference to study objectives:
The study shows a substantial reduction in drug-related hospital-treated incidents of somatic disease (HTIs) during opioid maintenance treatment compared to the pretreatment period. The reduction comprises overdoses, injecting-related and other drugrelated HTIs.
Overdoses are the most frequent cause of death among dependent opioid users, and the 64 % reduction in overdoses during treatment is an important finding.
Several studies have documented reduced mortality during OMT compared to the pretreatment period, and the reduction in overdoses found in the present study supports previous findings of reduced mortality during OMT.
Injecting-related HTIs were also substantially reduced (by 83 %) during OMT.
This may have been due to those OMT patients who stopped injecting and to others who continue to inject do so but at a less frequent rate than before treatment. The may be even greater than that due to bloodborne infections. The present study found that such bacterial infections were frequent among dependent opioid users and that they were substantially reduced during maintenance treatment.
Non-drug-related HTIs were found to increase (by 35 %) during treatment as compared to the pre-treatment period. Inpatient days increased by 98 % and outpatient treatment contacts increased by 40 %. The reason for this may be a closer contact with health services during maintenance treatment. Within the OMT program, patients may receive health care that was not previously available to them which leads to the diagnosis and treatment of health problems that were previously not identified. If so, this increase in non-drug-related HTIs may be reflective of improved access to health services and not of an increase in morbidity. It is theoretically possible that the cause is adverse OMT-effects, but we have not found any evidence in that direction in our scrutiny of the hospital records.
Limitations 19
Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias:
The study has some limitations. First, the study assessed acute/subacute hospital-treated disease incidents (HTIs) and not morbidity as such. A key question is whether changes in pre-during-post-OMT incidence and treatment rates reflect a change in morbidity; in other words whether these rates can be regarded as a proxy indicator for morbidity. Information on hospital treatment outside the local area was based on patient recall and some disease incidents prior to treatment may have been overlooked. In addition, closer contact with health services during OMT probably increases patients' help-seeking resulting in hospital treatment for health problems that would not have been treated before OMT. Further, the patients were five years older during OMT than in the pre-OMT period, causing an age-dependent increase in morbidity. Even so, we found significant reduction in HTIs during OMT. Therefore, our findings most probably reflect a "true" reduction in acute/subacute HTIs -and hence in acute/subacute morbidity -during compared to before OMT.
A further limitation is that the list of diagnoses to differentiate whether HTIs were drug-related or not has not been validated by external researchers and we could find no similar list in the literature. There may be some uncertainty about whether some HTIs were drug-related or not: however, inter-rater reliability scores were high. There
were also analytic problems due to the fact that the post-OMT observation period was only 91 years vs 1000 before and 813 during OMT. This is mainly due to the high retention in OMT in Norway. The relatively few post-OMT years at risk is a limitation in the study, but with this design and the given retention in treatment, the post treatment period will no matter be unbalanced compared to the pre-and in-treatment periods. concern that should be further studied.
Interaction between OMT status and various patient characteristics were examined;
Individuals with less work experience and fewer years of opioid dependence respectively showed less reduction in incidence rates during compared to before treatment. Patients with ongoing illicit drug-taking showed less reduction in HTIs than those not taking drugs, even so the quartile taking most illicit drugs showed significant HTI reduction during vs before treatment. Patients with interrupted treatment showed less HTI reduction during treatment than those with continuous treatment, but even the cessation group showed significant reduction.
Limitations: These are discussed in section 19. Both recall bias among participants, changed/increased use of health services during treatment and increased age will tend to make it more difficult to demonstrate HTI reduction during vs before treatment.
When such a reduction in spite of this was established, this reinforces the probability that the HTI reduction corresponds to a reduction in acute/sub-acute morbidity during vs before OMT.
Relation to other studies: Some studies imply health improvement during OMT based on patient interview (Australia) and clinical assessment (Germany) and register studies from Sweden indicates reduced volume of inpatient treatment due to infections during OMT. However, no studies on changes in somatic morbidity according to OMT status with a somewhat similar design were found. Hence, this study should provide new knowledge about OMT-related effects on somatic co-morbidity among dependent opioid users.
Generalisability 21
Discuss the generalisability (external validity) of the study results
Participation rate was high and selection bias was of limited importance, this should strengthen the external validity.
The study was performed within the Norwegian OMT setting. Special characteristics among dependent opioid users in Norway are that HIV prevalence is low and frequency of opioid injection, especially heroin, is high.
Further, the study was conducted in an area without major cities, and major cities tend to attract socioeconomic deprived dependent problem opioid users.
In spite of this, the generalisability should be fairly high, nevertheless further studies on OMT-related changes in morbidity should be undertaken.
Other information Funding 22
Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based:
There was no external funding for this study, the study was performed as part of the authors' employment as stated in the affiliation paragraph.
*Give information separately for exposed and unexposed groups.
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at http://www.strobe-statement.org.
